Concepedia

Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era

Prasanth Ganesan, Trivadi S. Ganesan, Venkatraman Radhakrishnan, Tenali Gnana Sagar, Krishnarathinam Kannan, Manikandan Dhanushkodi, Jayachandran Perumal Kalaiyarasi, Nikita Mehra

Indian Journal of Hematology and Blood Transfusion · 2018 · 13 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

, , +12

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 1K citations · Full text

, , +13

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 962 citations

, , +13

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

David Marín, Alexandra Bazeos, François-Xavier Mahon et al. · Journal of Clinical Oncology · 2010 · 901 citations · Full text

, , +13

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Hannah Bower, Magnus Björkholm, Paul W. Dickman et al. · Journal of Clinical Oncology · 2016 · 886 citations · Full text

, , +14